Substitution of oral for intravenous cyclophosphamide in membranous nephropathy
medcases00
Published on Feb 7, 2022
https://www.asn-online.org/media/podcast/K360/2020_09_24_KID0002802020.mp3
Sep. 24, 2020 - CONTRIBUTORS - Drs Leonella Luzardo, Gabriela Ottati, Jimena Cabrera, Hernando Trujillo, Mariela Garau, Carlota González Bedat, Ruben Coitiño, MarÃa H. Aunchayna, José Santiago, Graciela Baldovinos, Ricardo Silvariño, Alejandro Ferreiro, Francisco González-MartÃnez, Liliana Gadola, Oscar Noboa and Hena Caorsi
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
00:04New Vancomycin Dosing Guidelines for Hemodialysis Patients: Rationale, Caveats, and Limitations
185 views 1363 days ago -
Watch Later
00:04Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
126 views 1363 days ago -
Watch Later
00:04Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
92 views 1363 days ago -
Watch Later
00:04Should Buttonhole Cannulation of Arteriovenous Fistulas Be Used? Moderator Commentary
92 views 1363 days ago -
Watch Later
00:04 -
Watch Later
![Real-Life Prescribing of SGLT2 Inhibitors: How to Handle the Other Medications, Including Glucose-Lowering Drugs and Diuretics]()
00:04 -
Watch Later
![A Post Hoc Analysis of Statin Use in Tolvaptan ADPKD Pivotal Trial]()
00:04A Post Hoc Analysis of Statin Use in Tolvaptan ADPKD Pivotal Trial
119 views 1349 days ago
